SSA
RAIN

Schonfeld Strategic Advisors’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,700
Closed -$22.1K – 2335
2023
Q3 		$22.1K Buy
25,700
+3,200
+14% +$3.5K ﹤0.01% 1562
2023
Q2 		$27K Buy
22,500
+3,600
+19% +$18K ﹤0.01% 1874
2023
Q1 		$165K Buy
+18,900
New +$175K ﹤0.01% 1585

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's RAIN Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2023, closing a stake of 25,700 shares — an estimated $22.1K sold.

Schonfeld Strategic Advisors first reported a position in RAIN in Q1 2023 and held it in 3 quarters. The position peaked at $165K in Q1 2023. 58 funds tracked by Wall St. Rank hold RAIN as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 25,700 Rain Oncology Inc. Common Stock shares in Q4 2023, an estimated $22.1K.
  • Schonfeld Strategic Advisors first reported a position in Rain Oncology Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Rain Oncology Inc. Common Stock position peaked at $165K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.